Europe Preclinical In-vivo Imaging Market Research Report - Segmented By Modality, Reagent, By Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2024 to 2029)

Published: January, 2024
ID: 534
Pages: 137

Europe Preclinical In-vivo Imaging Market Size & Growth (2022 to 2027)

The preclinical in-vivo imaging market in Europe is growing faster for the past few years and is to hit the highest CAGR in the review period. Preclinical in-vivo imaging plays a crucial role in the research centers while developing new techniques. It has many applications in manufacturing a new drug. It ensures the safety and effectiveness of the new drug developed before clinical use. It helps to have a clear visualization of living animals while performing preclinical research. Modern technologies are taking part in manufacturing highly specified features in the preclinical in-vivo imaging market. Different techniques are used for anatomical imaging and molecular visualizations in research centers and theses techniques will determine changes in animals responding to physiological and environmental changes at the organ, tissue or molecular levels. 

Increasing incidences of various health disorders especially cancer and cardiovascular problems is boosting up the demand of the market in Europe. Also, the growing prevalence of the effective treatment procedures at any cost along with increasing disposable income is lavishing the growth rate of the preclinical in-vivo imaging market. Escalating expenditure on healthcare is also one of the factors propelling the demand of the market to the extent. The rise in the awareness of anatomical imaging techniques is expanding the growth rate of the market. 

However, the cost of installation and maintenance of the equipment is a bit expensive and cannot be affordable by small scale organizations. This attribute is slowly hindering the demand of the market. Lack of standardization is also inhibiting the growth rate of the market. The major challenging factor for the market lies in the less availability of skilled technicians and also growing complex issues in real-time. 

Rising support from government and non-government bodies through investments in developing new drugs with high quality is creating growth opportunities for the market. Besides, the emergence of advanced technology and the launch of innovative products are promoting the growth rate of the preclinical in-vivo imaging market in Europe. 

This research report on the Europe Preclinical In-Vivo Imaging Market is segmented and sub-segmented into the following categories:

By Modality:

  • optical Imaging
  • Nuclear Imaging
  • Micro-MRI
  • Micro-CT
  • Micro-ultrasound
  • Photoacoustic
  • Magnetic Particle Imaging Systems

By Reagent:

  • optical Imaging Reagents
  • Nuclear Imaging Reagents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, Europe is leading with the highest shares of the market. Germany and UK are among the major countries contributing the largest shares to the market with the increased revenue and also rising elderly population. France, Italy, and Spain among other countries in Europe are to have a significant growth rate in the coming years.

Top companies in this market profiled in the report are MR Solutions (UK), Mediso Miltenyi Biotec GmbH (Germany), and others are key players in the Europe preclinical in-vivo imaging market.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample